National Cancer Institute   U.S. National Institutes of Health | www.cancer.gov
Application Logo
Model Characteristics - Model: Rat NG2-expressing glial precursor cells are a new potential
oligodendroglioma cell initiating population in ENU-induced
gliomagenesis 
Model Descriptor Rat NG2-expressing glial precursor cells are a new potential
oligodendroglioma cell initiating population in ENU-induced
gliomagenesis
Official Nomenclature
Genotype
Species Rat (Rattus norvegicus)
Strain Sprague-Dawley 
Is This a Tool Strain? No
Developmental Stage
(applies only to Zebrafish)
 
Experimental Design Here, we investigated the cellular origin of low-grade gliomas in a rat model based on transplacental exposure to N-ethyl-N-nitrosourea (ENU). Longitudinal magnetic resonance imaging coupled to immunohistological and immunocytochemical analyses were used to further characterize low-grade rat gliomas at different stages of evolution. 
Phenotype We showed that early low-grade gliomas have characteristics of oligodendroglioma-like tumors and exclusively contain NG2-expressing slow dividing precursor cells, which express early markers of oligodendroglial lineage. These tumor-derived precursors failed to fully differentiate into oligodendrocytes and exhibited multipotential abilities in vitro. Moreover, a few glioma NG2+ cells are resistant to radiotherapy and may be responsible for tumor recurrence, frequently observed in humans. Overall, these findings suggest that transformed multipotent NG2 glial precursor cell may be a potential cell of origin in the genesis of rat ENU-induced oligodendroglioma-like tumors. This work may open up new perspectives for understanding biology of human gliomas.
Website for add. info  
Breeding Notes

 

Sex Distribution of the Phenotype  
Submitted by caMOD, Curator
Principal Investigator / Lab Baudier*, Jacques
Comment  
 
Model Availability: This model is available from
Strain Distributor Stock number
 
Comments Comments (Please login to submit new comments)
  CONTACT US     DISCLAIMER     ACCESSIBILITY     APPLICATION SUPPORT  
National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov